S. Lucas

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

D. Price, H. Magnussen, N. Roche, 2021, Respiratory Research.

Point‐of‐care biomarkers in asthma management: Time to move forward

I. Pavord, D. Price, H. Magnussen, 2020, Allergy.

Trends of testing for and diagnosis of α1-antitrypsin deficiency in the UK: more testing is needed

J. Soriano, M. Miravitlles, Rupert Jones, 2018, European Respiratory Journal.

Modern epidemiology of alpha1-antitrypsin deficiency (AATD) in the UK

Iain, J. Soriano, M. Miravitlles, 2018 .

A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care

D. Price, N. Papadopoulos, C. Murray, 2021, European Respiratory Journal.

Hypophosphataemia following ferric carboxymaltose and ferric derisomaltose: case closed, but questions remain

M. Garg, Ayushi Chauhan, S. Lucas, 2023, Gut.

Towards Optimum Reporting of Pulmonary Effectiveness Databases and Outcomes (TORPEDO): identifying a core dataset for asthma and COPD studies

D. Ryan, J. Soriano, N. Roche, 2021, medRxiv.